Drug Trial Radar · NCT00531947
Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression
Last checked: Nov 20, 2026Latest source record: Jan 15, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
308
Actual
Start
Jul 2007
Primary completion
Oct 2010
Study completion Oct 2010
Sponsor
- Lead sponsor
- Somerset PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Sep 19, 2007
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of your participation in this study is to help answer the following research question: Whether 12-week administration of EMSAM (selegiline transdermal system) is safe and effective for the treatment of adolescents (aged 12 through 17 years) with Major Depressive Disorder (MDD).
Conditions
- Major Depressive Disorder
Interventions
Selegiline Transdermal SystemDrug
EMSAM 6mg, 9mg, or 12mg Flexible Dose- 1 patch/24 hours- 12 Week Study
PlaceboDrug
Matching Placebo for EMSAM 6mg, 9mg, or 12mg Flexible Dose- 1 patch/24 hours- 12 Week Study
Primary outcomes
What the sponsor says the trial is designed to measure.
- CDRS-R Total Score (Child) (mITT w/LOCF Population) Week 12Time frame: baseline and 12 Weeks
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Dr. Nelson Handal
Dothan, Alabama
Dr. Mohammed Bari
National City, California
Dr. Michael McManus
San Diego, California
Dr. Elias Sarkis
Gainesville, Florida
Dr. Scott Segal
North Miami, Florida
Dr. Mary Stedman
Tampa, Florida
Dr. Irving Kolin
Winter Park, Florida
Dr. Rory Murphy
Overland Park, Kansas
Dr. Andrew Sediloo
Owensboro, Kentucky
Dr. Bruce Waslick
Springfield, Massachusetts
Dr. Christopher Kratochvil
Omaha, Nebraska
Dr. Ann Childress
Las Vegas, Nevada
Dr. Melissa DelBello
Cincinnati, Ohio
Dr. Leland Dennis
Oklahoma City, Oklahoma
Dr. David Brown
Austin, Texas
Dr. Alain Katic
Bellaire, Texas
Dr. Graham Emslie
Dallas, Texas
Dr. Mary Shemo
Charlottesville, Virginia
Dr. John Gilliam
Richmond, Virginia
Dr. Arifulla Khan
Bellevue, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.